Is NMN FDA Approved?

Updated November 3, 2026. For information only, not medical advice or legal advice. This guide has no affiliate links, and we do not link to NMN products.

Related: Is NMN legal in the US?

Short answer

Basis: FDA, “Information for Consumers on Using Dietary Supplements” (content current as of October 21, 2022); FDA letter, Docket FDA-2023-P-0872 (opened November 3, 2026); Google autocomplete (Nov 3, 2026).

No. The FDA does not approve dietary supplements before they are sold, so “approved” is the wrong test for NMN. The FDA says that under the law that governs supplements it “is not authorized to approve dietary supplements for safety and effectiveness before they are marketed.” Its 2025 letter on NMN is about classification. It is not a safety finding or an approval.

What does the FDA letter say, in its own words?

Basis: FDA letter of September 29, 2025, Docket FDA-2023-P-0872, section II.B.

It says:

“we now conclude that NMN is not excluded from the definition of dietary supplement under section 201(ff)(3)(B)”

In plain terms, the law can keep an ingredient out of the supplement category if it was authorized for study as a new drug before it was sold as a supplement. The FDA now says NMN was sold as a supplement in the US first.

Why did the FDA change its position? Is NMN still banned?

Basis: US Google autocomplete, Nov 3, 2026 (“is nmn still banned by fda”); FDA letter, sections I.C, II.A.4.b and II.B.

The letter does not use the word “banned”, so “is NMN still banned by the FDA?” has no direct answer in it. It does reverse an earlier position: on October 11, 2022, the FDA told one company that NMN was excluded from the supplement definition, and it sent similar letters to other firms. In 2025 the FDA changed how it reads the rule. It said it “is aware of evidence that NMN was marketed as a dietary supplement in the United States as early as 2017”, which came before NMN was authorized for investigation as a new drug.

What the letter does not tell you

Basis: FDA letter, footnotes 41 and 44; FDA consumer page above.

• Not a safety or effectiveness finding. The letter says a product’s safety profile does not decide whether it was marketed as a supplement.
• Not a free pass. The FDA can still use seizures and recalls to remove an unsafe or adulterated supplement.
• Still under review. The FDA said it continues to examine the evidence on NMN’s US marketing.

Asking whether NMN is banned or illegal in the US? See Is NMN legal in the US? Trial evidence is in our NMN guide, NMN vs NR and how to choose an NMN supplement. For a NAD+ supplement we cover, see our NR guide.

Where to read more

Availability varies by country; check local rules before buying. We do not link to NMN products.

FAQ

Is NMN FDA approved?

No. The FDA does not approve dietary supplements before they are marketed. Its 2025 letter concluded that NMN is not excluded from the supplement definition under one section of the law. It did not approve NMN or say NMN is safe or works.

Basis: US Google autocomplete, Nov 3, 2026 (“is nmn fda approved”); FDA consumer page; FDA letter, Docket FDA-2023-P-0872.

Why is NMN not FDA approved?

Because supplements are not approved before sale, under the FDA’s own description of the law. In the letter, the FDA described NMN as “authorized for investigation as a new drug”, which is a research status, not a drug approval. The letter does not say NMN is safe or effective.

Basis: US Google autocomplete, Nov 3, 2026 (“why is nmn not fda approved”); FDA consumer page; FDA letter, section II.B.

Is NMN safe for humans?

In a 2026 meta-analysis of short trials (14 days to 24 weeks), oral NMN did not increase adverse events. Long-term safety is not established, and the FDA letter is not a safety finding. See our NMN guide for the studies, and ask a clinician if you take medicines.

Basis: US Google autocomplete, Nov 3, 2026 (“is nmn safe for humans”); PMID 42514320.

Sources

Pages were opened on November 3, 2026.

1. US Food and Drug Administration. Response to citizen petition, Docket FDA-2023-P-0872 (letter dated September 29, 2025; the PDF’s date line misprints the year as 2029). Read from the official regulations.gov PDF.
2. US Food and Drug Administration. Information for Consumers on Using Dietary Supplements (content current as of October 21, 2022).
3. Yang W et al. Safety and metabolism-related outcomes of oral nicotinamide mononucleotide supplementation in adults: a systematic review and meta-analysis. Nutrients, July 10, 2026. PubMed

This article is for information only and is not medical advice. Speak to a healthcare professional before changing medication or supplements.